chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A spontaneous report was received from a 21-year-old, female patient who received COVID-19 vaccine (mRNA-1273) and experienced arm pain, headache, Nausea and joint pain. The patient's medical history was not provided. Concomitant medications were included unknown birth control. On 04 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot: 03K20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 04 Jan 2021, immediately after, the patient experienced side effects like arm pain, headache, nausea and joint pain. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event, arm pain, headache, Nausea and joint pain, were unknown.; Reporter's Comments: This case concerns a 21-year-old female who experienced NS unexpected event of pain in extremity and NS expected events of headache, nausea, arthralgia.  Event onset occurred the same day as the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
60% of dose given. Patient has a developemental delay and was unable to tolerate vaccine process. First attempt was made and 0.3mL of 0.5mL dose was given. Distraction and redirection techniques were attempted by patient?s care giver and staff members. Second attempt was made but again,  patient was unable to tolerate and care giver advised vaccine adminsitrator to stop.
09/08/2021 to try to stand up, I could not stand up straight.  I was all hunched over. I called my PCP and he referred me to Orthopedic.  He also referred me to the Physical Therapist.  The hip doctor said there was not anything wrong with my hip, it was my back.  During the meantime, my knee became swollen. I am currently in a recliner with an ice pack on my back and ice on my knee. I am in PT and taking Gabapentin for nerve pain. I mostly wonder if the Pfizer made everything inflammatory because everything is inflamed. Prior to the vaccine, I did not have the inflammation that is so annoying right now.
PT SUFFERED FROM HIVES, RASHES AND A MILD GRADE FEVER FOR 7 DAYS FOLLOWING VACCINATION. THE PT RECEIVED TX WITH PREDNISONE AND RECOVERED WITHIN DAYS.
This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient stated that she almost had all the side effects: she has no energy, been laying around for 6 days and felt like she have the flu or a cold, Thursday night (unspecified date), she had injection site pain, felt tired, has headache, muscle pain, chills, joint pain and fever. She has gotten better but now she has headache and can't get out of bed, feel dizzy. The patient recovered from the chills and fever on an unspecified date. Outcome of other events was not recovered and she was wondering when will all the other symptoms will go away, The patient was scheduled for 2nd dose on 14Feb2021. Follow-up attempts are completed. The following information on the batch number has been requested.
On 07/18, I woke up with a slight scratchy throat. On 07/19, I had a sore throat, body aches, coughing, and some congestion. Those symptoms continually increased until 07/21. On 07/21, I started running a 101 degree fever. On 07/22, I could really feel it in my chest and was nervous about how it was progressing as I have asthma from previous pneumonia infections. I reached out to my doctor for the antivirals as we were out of town. I didn't start feeling somewhat better until Sunday or Monday. My congestion is almost cleared up, but I still have a scratchy throat and coughing. Otherwise, I'm feeling alright. I took another COVID-19 test this morning and it was still positive. I took MOTRIN Tuesday through Friday to help with the body aches. I used my PROAIR inhaler as needed.
BRUISING; NUMBNESS IN LEFT SIDE; TINGLING IN LEFT SIDE; WEAKNESS; HEADACHE; This spontaneous report received from a consumer concerned a 47 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No known drug abuse or illicit drug usage, alcohol usage or smoking. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, expiry: 24-OCT-2021) dose was not reported, administered on 04-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 04-AUG-2021, the patient experienced bruising. On 04-AUG-2021, the patient experienced numbness in left side. On 04-AUG-2021, the patient experienced tingling in left side. On 04-AUG-2021, the patient experienced weakness. On 04-AUG-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling in left side, weakness, headache, bruising, and numbness in left side. This report was non-serious.
Tuesday 9/14/21: A fine rash appeared around her mouth. Sore throat, headache Wednesday 9/15/21: More facial rash, sore throat, tired. In the evening huge face rash flare, trouble breathing. Arms, legs, swollen and red with rash. Thurs. 9/16/21: woke up with eyes swollen shut. Rash still inflamed. Went to ER Friday 9/17: less severe facial swelling, severe rash Rash has persisted through now. We are still searching for help/treatment
Given outside of approved schedule (too early). Patient was inoculated with dose 2 on day 15, rather than day 21.
Itchy skin and Dermatographia. Still present but has not been as bad as after my first booster.
No additional AE reported.; VARIVAX reconstituted with normal saline instead of the supplied sterile diluent was administered to a patient.; This spontaneous report was received from a nurse and refers to a patient of an unknown age or gender.  The patient's medical history, concurrent conditions, concomitant therapies and previous drugs reactions or allergies were not reported.  On 29-SEP-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) at a dose of 0.5 ml, lot #U016061, expiration date reported as 01-SEP-2023 however it was verify as : 20-MAY-2023, administered as prophylaxis (strength, and route of administration were not provided) reconstituted with normal saline instead of the supplied sterile diluent (vaccine incorrect diluent used). No additional adverse event was reported.
Exactly 2 weeks after dose 2, I began experiencing painful urination. 2 days later, I came down with genital herpes outbreak for the first time in my life. I have had monogamous relationship for 2 years and my partner has no signs of infection. I have never to my knowledge been exposed to or had herpes 1 or 2
@ 1030PM on 30SEP92; mom 1st noticed red bite like area; rt cheek that started spreading across cheek & under eye; swelling started to go down a/3AM; both cheeks swollen & red area lt hand, rt ankle & heel; red patches; took to ER;felt hot
Site of injection developed some kind of lump that has increased in size since vaccination.  I have seen my primary care Dr. and she wants me to go to my dermatologist to have it removed. It  hurts to touch it and it keeps bothering me. I was recommended to report this by the pharmacist today.
Patient became very dizzy after receiving second vaccine (TWINRIX), no medical treatment needed. Patient was given glass of water. His legs were elevated on the chair, and he rested for about 30 minutes.
injection site pain; massive redness; swelling; bad headache; muscle and joint pain; muscle and joint pain; tiredness; feeling unwell; This is a spontaneous report received from a contactable consumer. A 75-years-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), via an unspecified route of administration on Right arm on 04Feb2021 02:45 PM at single dose.Patient Medical history included arthritis, hypertension, osteopenia. Historical vaccine included first dose of bnt162b2 via an unspecified route of administration (lot number: EL9265) on left arm on 14Jan2021 04:30 PM at Single Dose for COVID-19 immunisation. Concomitant medication included Amlodipine Besylate 2.5mg, Citalopram 10, captopril (METOPRIL). On 04Feb2021 22:30 patient experienced injection site pain, massive redness, swelling, bad headache, muscle and joint pain, muscle and joint pain, tiredness, feeling unwell after vaccination. patient was not pregnant, No  treatment received for AE, patient had not Covid tested post vaccination, patient had allergies to Codine. Outcome of events was recovering.   Information on the lot/batch number has been requested.
1 of 2 pt vaxed from the same lot# who exp an adverse event;pt vaxed 6FEB95 devel tender, warm, swollen arm w/urticaria @ 12 hrs p/vax;rx-DPH;also exp malaise;resolved w/in 7 days;last pneumococcal vax 1987
This information has been received from a Licensed Practical Nurse concerning a 2 year old female patient. The patient had no pertinent medical history, drug allergies, concurrent conditions or concomitant therapies. On an unknown date, the patient was vaccinated with VARIVAX with lot number reported as I017146 and expiration date on 13-MAY-2017 (dose, dose number, route of administration and anatomical location were not provided), administered for prophylaxis with its sterile diluent (manufacturer unknown) (lot number and expiration date were not provided). On 09-MAY-2017, the patient visited the office. The nurse reported that a culture was performed and the patient tested positive for Varicella. The patient had being treated with Acyclovir. At the time of the report, the patient had no recovered from varicella and the causal relationship between VARIVAX, its sterile diluent (manufacturer unknown) and the event was unknown. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of blood glucose increased in a 69-year-old male patient who received BOOSTRIX (batch number 3NS3A, expiry date 18th November 2016). Concurrent medical conditions included diabetes. On 4th May 2016, the patient received BOOSTRIX. In May 2016, less than a month after receiving BOOSTRIX, the patient experienced blood glucose increased. On an unknown date, the outcome of the blood glucose increased was unknown. The reporter considered the blood glucose increased to be unlikely related to BOOSTRIX. Additional details were provided as follows: The patient also received a steroid and antibiotic at the same time along with BOOSTRIX. The patient had discontinued steroid and antibiotics.
Vaccine was administered by the Health Department nursing staff at the local high school. Hives and trouble breathing (wheezing) started about an hour after the vaccine was administered. Redness and swelling of the left arm started a few hours after vaccine was administered. Mother was called by the school nurse to come pick up the pt as soon as the hives started. Mother called the pt's allergist at hospital but was not taken to the ER, urgent care, or PCP. Pt was given Zyrtec and Benadryl per mother. Wheezing stopped at about 3 pm. Hives and redness/swelling in left arm are still present.
Information has been received from a licensed practical nurse concerning a 12 year old male who on 20-MAY-2011 was vaccinated IM with a 0.5 ml dose of GARDASIL (lot number: 665607/1333Y). Concomitant therapy included meningococcal vaccine (unspecified). On 21-MAY-2011 the patient broke out in a rash on his face, trunk and arms. The patient sought unspecified medical attention and was prescribed BENADRYL for treatment. Therapy was also reported as discontinued on 21-MAY-2011. Upon the time of the report, the patient's present status was unknown. Additional information has been requested.
I developed  high blood pressure after receiving my first COVID-19 vaccine. I continue with high blood pressure and need daily medication for it.
This spontaneous report was received from a pharmacist referring to a 71 year old female patient. The patient had not drug reactions/allergies. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 14-NOV-2018, the patient was vaccinated with PNEUMOVAX 23, lot # reported as R012916 with expiration date reported as 25-NOV-2020, intramuscularly, for prophylaxis (dose and anatomical location were not reported). On 15-NOV-2018, the patient began to experience pain, redness and swelling that moved from the injection site down to the elbow. It was stated that the patient reported this to the pharmacist and no treatment was given for the events. At the time of reporting, the outcome of the events was reported as not recovered. The causality assessment between the events and PNEUMOVAX 23 was not provided. Lot number R012916 is an invalid lot number for PNEUMOVAX 23.
Red tender irregular splotch, upper left arm, beginning and inch below injection site, two days after 2nd vaccine. Some tingling sensation around thumb area.
INJECTION WAS  GIVEN  AFTER THE ALLOWED TIME AFTER FIRST VIAL PUNCTURE
This spontaneous report was received from a Licensed Nurse and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date (reported as "on unknown recent dates") the patient was administered an improperly stored dose of PROQUAD injection, subcutaneously, for prophylaxis (dose and anatomical location were not reported). The lot number was reported as N014366 with expiration date on 09-MAY-2019, which is not a valid lot number for the product. No adverse effects were reported for the patient after the administration of PROQUAD. The vaccine underwent a temperature excursion of 14.9F for 12 hours and 6 minutes and no previous temperature excursions were reported. The reporter stated that the call was because of a data logger. This is one of two reports received from the same reporter (MARRS # 1712USA005251). Sender's Comments: US-009507513-1712USA005251.
I got pregnant about 2 weeks after recieving the 2nd dose of my vaccine. About 6 weeks later , I started bleeding. I saw my Dr. they tested the HCG levels. The fetus was measuring 5 weeks even though I was 8 weeks.
Seizure > 30 minutes <24 hours after 12 month immunizations (ProQuad #1, Comvax #3, Prevnar #4) previously healthy. EEG, MRI, CT, LP - normal. Treatment: oxcarbazepine.  02/07/2007 Hospital ER record received for ER visit following first episode of seizure activity which occurred the night of this 1 yr. old's vax.  Child was found by father in crib with rhythmic jerking noted on the right side of her body.  Left side of body was not moving at all.  She was transported via EMS to ER where the seizing was noted to have stopped but left hemiparesis and left eye deviation remained.  PE: Infant was quiet and subdued, minimally responsive. Initially flaccid on the left side. Generalized hypotonia. Leftward gaze. Otherwise WNL. Impression: Prolonged seizure with left sided weakness.  Possible Todd's paralysis. Principal DX:  Left Hemiplegia, seizure 02/16/2007 D/C Summary and Pediatric neurologic Re-evaluation received.  Neuro eval for status epilepticus reports child is almost back to normal with MRI (-) and EEG (-).  Discharge DX: Todd's Paralysis. 2' DX: first seizure.
After vaccine administration, staff realized vial of vaccine was not diluted.  Mother was contacted by pharmacist 11/25/22 and reported no issues. Pharmacist followed up 11/26/22 and mother still reported no issues.
A few hours, post vax, the pt started having symptoms of fever (101.7F), congestion, cough, runny nose, sore throat and anorexia. Also, noted swelling and redness at site. Examined by FNP the next day, who noted a 5cm red, raised area at injection site. Treated with Tylenol. On 9/14/00, call to report possibly a vaccine reaction. Saw the doctor who stated that a few hours, post vax of IPV on 9/12/00, pt came down with a temperature of 101.7F, congestion, cough, stuffy nose, sore throat and lethargy. No vomiting. Anorexia and redness at injection site. Pt had irregular areas "about the size of a quarter" per dad. Seen by doctor on 9/13/00. Per dad, temperature was 101F on 9/14/00 and today on 9/15/00, the temperature is 99.6F with redness at site is beginning to go down per dad but is still at home sick and dad thinks he may be coming down with something now. Asked dad to call if he has further concerns or anything else happens that is unusual.
I am achy all over really bad; Fever; Don't feel good; This is a spontaneous report from a contactable consumer. This consumer (Patient) reported. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date 08Feb2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date on Jan2021 as dose 1, single for covid-19 immunisation. On an unspecified date on Feb2021, the patient experienced achy all over really bad, fever and patient don't feel good. The outcome of the events were unknown.  Information about lot/batch number has been requested.  Follow-up (16Apr2021): This is a spontaneous report from a contactable consumer. This consumer (Patient) reported: suspect product details and Historical vaccine  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
J&J vaccine 4/2/21. Pfizer 11/30/22. Hospitalized with COVID infection 7/1/22
Left foot ankle rash described as red and slightly raised approx 4.5inx2in
pt stated that she had bad pain in her left arm, shoulder, and breast.  This pain lasted about 3-4 days.  Pt stated she developed a burning, sore rash over a week after taking the vax.  The rash is underneath her left arm pit, back, and chest.   She says her muscles feel very sore.  Pt has only taken Tylenol, Ibuprofen, and using an allergy cream.  Pt will call PCP regarding her symptoms.
PedvaxHIB was given by RN without order being present. Patient not due for vax until 12 months.
facial clicking; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program from a Pfizer-sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FACIAL DISCOMFORT (non-serious), outcome "unknown", described as "facial clicking". Additional information: The reporter believes she had a reaction after her 1st dose with facial clicking. She stated she told the nurse and they just gave her a bottle of water and didn't record anything. She was wanting to know if she should get her 2nd dose or not.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. .
Right arm  & hand numb & tingly, pins & needles. 2 days later it moved to my left arm & hand & now also my calves.
"I had to go to the doctor office due to sensitivity, soreness in the right armpit and tenderness in both breasts after receiving the first shot.  This occurred approximately 3 days after the first inoculation and continued for 10+ days with the breast tenderness continuing to be an issue.  The second shot was extreme fatigue for 2 days, and the continuing breast soreness."
Got into an accident; Spasm in left arm to fingers; Headache; Pain in the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACCIDENT (Got into an accident), MUSCLE SPASMS (Spasm in left arm to fingers), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in the injection site). On 10-Mar-2021, the patient experienced ACCIDENT (Got into an accident) and MUSCLE SPASMS (Spasm in left arm to fingers). At the time of the report, ACCIDENT (Got into an accident), MUSCLE SPASMS (Spasm in left arm to fingers), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Information has been received from an office manager who reported a patient (age, sex not reported) was administered CERVARIX for the second dose, instead of GARDASIL. Office manager reported she would have the physician call back and ended the call. No further information was provided. Additional information has been requested.
other zoster related conditions; Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.     On or about 20-OCT-2013, the patient was inoculated at a pharmacy with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, route of administration and anatomical location were not reported) for the long-term prevention of shingles and zoster-related conditions. Subsequently, on an unknown date, the patient was treated by healthcare providers for shingles, and other zoster-related conditions.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  The outcome of the events was unknown. The reporter considered events to be related to zoster vaccine live (ZOSTAVAX).